Another possibility is to require drugs to be sold to state Medicaid programs at lowest industrially advanced country pricing.
Another possibility is to require drugs to be sold to state Medicaid programs at lowest industrially advanced country pricing.
95% of what Medicaid does buy, the packaging, the advertising, the reporting to Medicaid is more expensive than the drug inside.